Introduction to Cannabis Abuse

A healthy young man presented to the emergency department with mild hemoptysis associated with cannabis abuse.

The analyzis by use of UPLC-MS/MS indicated that all samples were positive, reporting recent cannabis abuse.

MEASUREMENTS We assessed associations of annual hospitalizations for cannabis use disorder (assignment of a primary or secondary code for cannabis abuse and/or dependence using ICD-9-CM or ICD-10-CM (outcome)) with the total number of medical cannabis dispensaries per square mile in a ZIP code as well as dispensary temporal and spatial lags (primary exposures).

This study was conducted to evaluate the prevalence of cannabis abuse in multiple sclerosis cases and to evaluate the effect of cannabis on serum cytokines in such cases.

Utilizaram-se os instrumentos para coleta de dados: Questionário de dados sociodemográficos; Escala para Avaliação de Desordens devido ao uso de Álcool (AUDIT) e Cannabis Abuse Screening Test – CAST.

Outcome variable was frequency of cannabis abuse among these patients of first episode psychosis.

Results 32 year-old female patient with previous diagnosis of BPD, psychotic episodes and cannabis abuse, was admitted due to paranoid ideation and aggressiveness, with massive borderline defense mechanisms (frequent displays of anger, high impulsivity, low frustration tolerance, self-destructive behavior…).

Introduction: Because of the rising prevalence of cannabis abuse, cannabinoid hyperemesis syndrome (CHS) was recognized as a new medical diagnosis in 2004.

We report the case of a 41-year-old male convict with a 27-year history of cannabis abuse who suddenly died in the bed of his cell after having smoked buscopan® tablets.

A cohort of first-ever non-severe stroke adult patients was screened at baseline and three months post-stroke using recommended cut-off scores of standardized scales for tobacco, alcohol and cannabis abuse.

Results 32 year-old female patient with previous diagnosis of BPD, psychotic episodes and cannabis abuse, was admitted due to paranoid ideation and aggressiveness, with massive borderline defense mechanisms (frequent displays of anger, high impulsivity, low frustration tolerance, self-destructive behavior…).

8]) in Southern California (N = 1007) were classified by patterns of problematic cannabis use from the Cannabis Abuse Screening Test, using Latent Class Analysis.

48) and cannabis abuse (OR 1.

The variables were assessed through a battery based on the ESPAD survey, cannabis abuse screening test, cannabis use intention questionnaire and family climate scale.

The underlying causes of gastrointestinal symptoms which could be associated with ST segment elevation in the absence of either acute myocardial infarction or Takotsubo cardiomyopathy comprised pneumonia, pulmonary embolism, perforated gastric ulcer, intestinal obstruction, acute appendicitis, acute pancreatitis, acute cholecystitis, pheochromocytoma, bacterial meningitis, diabetic keto acidosis, and cannabis abuse.

Chronic cannabis abuse may cause degenerative pathological changes in the brain, also the effect of cannabis on cognition, memory and learning is well known.

2 Various drugs or toxic compounds can cause catatonia in youths, including steroids, lithium, phencyclidine, and cannabis abuse.

This study was aimed at exploring the associations between the risk of presenting a clinically relevant condition involving non-substance-related addictive or dysregulated behaviors (as measured by the MultiCAGE CAD-4 screening), and cannabis abuse/dependence (CAST/SDS) scores, and the role of gender therein.

OBJECTIVE To analyze the association between cannabis abuse and serious adverse events following elective spine surgery.

THC is the primary compound that drives cannabis abuse potential and is also used and prescribed medically for therapeutic qualities.

Here, we aimed to confirm the psychometric properties of a French version of the Cannabis Use Disorder Identification Test-Revised (CUDIT-R), and to compare its screening abilities with those of the Cannabis Abuse Screening Test (CAST), in subjects consulting in mental health settings.

Aim: To evaluate effectiveness of video assisted teaching programme on cannabis abuse on level of knowledge among undergraduate students.

The misuse was assessed by specific tests: dependence on smoking tobacco (Fagerstrom), Cannabis Abuse Screening Test (CAST) and Alcohol Use Disorders Identification Test (AUDIT).

This research aimed to evaluate severity of various psychotic symptoms in relation to variables of cannabis abuse.

Substance use was common, notably alcohol dependence (N=16, 15%), alcohol abuse (N=18, 16%), and cannabis abuse (N=18, 16%).

One-hundred-and-four young adults (78 women) were assessed in laboratory using self-report measures of Internet addiction, alcohol use disorder, cannabis abuse, depression, anxiety, and stress symptoms, impulsiveness, and obsessive-compulsive symptoms.

In a healthy population, the cognitive deficit is often linked with cannabis abuse, and although the same would be expected in patients with schizophrenia, research has presented contradictory results.

Objectives To explore the independent association between cannabis abuse and subsequent hospitalizations for acute pancreatitis (AP) and delineate the demographic differences among AP in patients with and without persistent cannabis abuse.

Physicians need to familiarize themselves with cannabis abuse or dependence as a risk factor for arrhythmia.

We report a 62-year-old woman with chronic cannabis abuse inducing MI complicated by cardiogenic shock, chronic dilated cardiomyopathy, and atrial fibrillation.

We also explored how frequency of cannabis use relates to stimulant use and whether subjects with a cannabis use disorder (CUD)–defined as cannabis abuse or dependence–are more likely to be recent users of cocaine or ecstasy.

Patients with a preoperative ICD-9-CM diagnosis of cannabis abuse (Cannabis) or dependence were identified.

These adverse psychiatric outcomes may reflect the negative impact of alcohol and/or cannabis abuse on neural systems mediating reward and/or error detection.

The patient was a 34-year-old woman with a 14-year history of cannabis abuse who, during withdrawal, showed epileptic spikes, without any corresponding clinical symptoms, and migraine attacks of increasing intensity and frequency.

, the new diagnostic term that covers both the previous concepts of cannabis abuse and dependence) can develop as a consequence of cannabis use and occurs in sub-sets of users; select symptoms of CUD include difficulties in use control, disruptions in functioning, and increased tolerance and withdrawal.

Results In CO compared with NY and OK, respectively, cannabis abuse hospitalisations increased (risk ratio (RR) 1.

A second set of hair specimens were obtained from 15 subjects with a known history of cannabis abuse.

Patients with preoperative cannabis abuse/dependence were identified.

Information on their sociodemographic data, cannabis use pattern, Cannabis Abuse Screening Test (CAST) and the main motivation for use were collected.

Patients were assessed for neurocognitive measures with a broad battery, genotyped for COMT Val158Met polymorphism from peripheral blood sample, and evaluated with a semi‐structured interview in order to establish the history of cannabis abuse.

However, the reasons why HS patients are more prone to cannabis abuse are unknown: one can hypothesize that cannabis could be a trigger of the disease or a consequence to the chronic pain associated with HS.

Unfortunately, the molecular mechanisms underlying behavioral impairment by cannabis abuse remain poorly understood.

Diffuse alveolar hemorrhage (DAH) is a rare and life-threatening complication of cannabis abuse.

The cannabis abuse screening trial score revealed risky use for 87.

Cannabis-using patients had an encounter diagnosis of cannabis abuse/dependence and/or ≥2 cannabis-positive urine drug screens.

Thus, it is likely that genetic mutations in FAAH gene may support a potential link between functional abnormalities in the endogenous cannabinoid system and cannabis abuse.

It is important to determine whether there are brain functional alterations within these networks in individuals that do not seek treatment for chronic cannabis abuse.

Cannabis abuse during adolescence is widespread and is associated with increased risk of psychoses later in life.

Cannabis abuse has been an issue of major concern for the Albanian society in recent years, following the wide illegal planting of the species.

Each patient completed self-administered questionnaires that assessed lifetime exposure to potentially traumatic events (Life Event Checklist for DSM-5), PTSD severity and diagnosis (PTSD Checklist for DSM-5), AUD severity (Alcohol Use Disorder Identification Test [AUDIT]), tobacco dependence (Fagerström test for Nicotine Dependence), cannabis dependence (Cannabis Abuse Screening test), and gambling disorder (Canadian Problem Gambling Index).

Psychotherapeutic treatment options of cannabis abuse and dependence are shown.

There are no consistent guidelines on the implications of cannabis abuse and dependence (CAD) in kidney transplant candidates.

Eleven patients (16%) consumed cannabis on a regular basis, and in 55% of them CUDIT scores suggested cannabis abuse or dependence.

To the best of our knowledge, epigenetic mechanisms have been previously studied in alcohol and cannabis abuse separately.

There are animal models available that can capture various aspects of cannabis abuse and detect signals that inform further development of CUD treatments.

RESULTS Compared to individuals reporting their most recent cannabis-using occasion as social, solitary users (n = 55) were significantly more likely to screen positive for psychosis, endorse more symptoms of cannabis abuse/dependence, report using cannabis to cope, and use cannabis on more days within the previous 30 days.